Skip to main content
SpringerLink
Log in

The Use of Stimulated EMG in the Diagnosis of Neuromuscular Junction Abnormality

  • Chapter
  • First Online:
Pediatric Electromyography

Abstract

Despite the increasing availability of genetic panels and their diminishing cost genetic screening for myasthenic conditions in children remains difficult. Additionally some children with undoubted myasthenic conditions have yet to be genetically characterised. For this reason a neurophysiological test for the diagnosis of disorders of the neuromuscular junction (NMJ) is valuable. Of the options available repetitive nerve stimulation up (RNS) is relatively insensitive and uncomfortable and reliance on a form of single fibre EMG (SFEMG) is essential. Volitional SFEMG presents formidable challenges in children and is unlikely to be successful in any child under the age of eight years. Stimulation techniques increase the feasibility of studies in children. A modification of stimulation SFEMG using concentric needle electrodes has been developed. Because multiple motor units are stimulated true single-fibre potentials are not seen with this technique and we therefore describe the technique as Stimulated Potential Analysis using Concentric needle Electrodes under the acronym SPACE. Examinations are conducted on orbicularis oculi being the most sensitive muscle in most myasthenic conditions. With the use of local anaesthetic it is possible to effect successful examination in most children. Monopolar needles are placed near the facial nerve as it crosses the zygomatic arch with the potentials recorded from orbicularis oculi. The use of peak detection algorithms on most EMG machines allows some quantification of the results producing a value for the Mean Consecutive Difference (MCD) and these are unaffected by the high-frequency filter used. Quantification of the MCD becomes increasingly difficult with increasing abnormality of the underlying NMJ. Normative data have been derived from the extrapolated norms (e-norms) technique. When applied to a large cohort of patients the technique demonstrates sensitivity 84%, specificity 71%, negative predictive value 96%, and positive predictive value 36% for the diagnosis of myasthenia. Specificity can be further enhanced if those conditions caused by a neurogenic abnormality are excluded. The technique is within the competence of any trained clinical neurophysiologist and is well tolerated by patients and parents alike. It is an important neurophysiological technique for the diagnosis of neuromuscular junction abnormality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beeson D. Congenital myasthenic syndromes: recent advances. Curr Opin Neurol. 2016;29:565–71.

    Article  CAS  PubMed  Google Scholar 

  2. Ravenscroft G, Davis MR, Lamont P, Forrest A, Laing NG. New era in genetics of early-onset muscle disease: breakthroughs and challenges. Semin Cell Dev Biol. 2017;64:160–70.

    Article  CAS  PubMed  Google Scholar 

  3. Shelton GD. Myasthenia gravis and congenital myasthenic syndromes in dogs and cats: a history and mini-review. Neuromuscul Disord. 2016;26:331–4.

    Article  PubMed  Google Scholar 

  4. Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015;14:420–34.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Eymard B, Hantai D, Fournier E, Nicole S, Sternberg D, Richard P, Fardeau M. Congenital myasthenic syndromes; French experience. Bull Acad Natl Med. 2014;198:257–70.

    Google Scholar 

  6. Rodriguez Cruz PM, Palace J, Beeson D. Congenital myasthenic syndromes and the neuromuscular junction. Curr Opin Neurol. 2014;27:566–75.

    Article  PubMed  Google Scholar 

  7. Eymard B, Hantai D, Estournet B. Congenital myasthenic syndromes. Handb Clin Neurol. 2013;113:1469–80.

    Article  PubMed  Google Scholar 

  8. Finlayson S, Beeson D, Palace J. Congenital myasthenic syndromes: an update. Pract Neurol. 2013;13:80–91.

    Article  PubMed  Google Scholar 

  9. Hantai D, Nicole S, Eymard B. Congenital myasthenic syndromes: an update. Curr Opin Neurol. 2013;26:561–8.

    Article  CAS  PubMed  Google Scholar 

  10. Engel AG. Current status of the congenital myasthenic syndromes. Neuromuscul Disord. 2012;22:99–111.

    Article  PubMed  Google Scholar 

  11. Lorenzoni PJ, Scola RH, Kay CS, Werneck LC. Congenital myasthenic syndrome: a brief review. Pediatr Neurol. 2012;46:141–8.

    Article  PubMed  Google Scholar 

  12. Nance JR, Dowling JJ, Gibbs EM, Bonnemann CG. Congenital myopathies: an update. Curr Neurol Neurosci Rep. 2012;12:165–74.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Barisic N, Chaouch A, Muller JS, Lochmuller H. Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes. Eur J Paediatr Neurol. 2011;15:189–96.

    Article  PubMed  Google Scholar 

  14. Pitt M. Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children. Dev Med Child Neurol. 2008;50:328–33.

    Article  PubMed  Google Scholar 

  15. Trontelj JV, Khuraibet A, Mihelin M. The jitter in stimulated orbicularis oculi muscle: technique and normal values. J Neurol Neurosurg Psychiatry. 1988;51:814–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Trontelj JV. Stimulation SFEMG in myasthenia gravis. Muscle Nerve. 1990;13:458–9.

    Article  CAS  PubMed  Google Scholar 

  17. Payan J. The blanket principle: a technical note. Muscle Nerve. 1978;1:423–6.

    Article  CAS  PubMed  Google Scholar 

  18. Parr JR, Andrew MJ, Finnis M, Beeson D, Vincent A, Jayawant S. How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia. Arch Dis Child. 2014;99:539–42.

    Article  PubMed  Google Scholar 

  19. Patel A, Gosk M, Pitt M. The effect of different low-frequency filters on concentric needle jitter in stimulated orbicularis oculi. Muscle Nerve. 2016;54:317–9.

    Article  PubMed  Google Scholar 

  20. Rodriguez Cruz PM, Belaya K, Basiri K, Sedghi M, Farrugia ME, Holton JL, Liu WW, Maxwell S, Petty R, Walls TJ, Kennett R, Pitt M, Sarkozy A, Parton M, Lochmuller H, Muntoni F, Palace J, Beeson D. Clinical features of the myasthenic syndrome arising from mutations in GMPPB. J Neurol Neurosurg Psychiatry. 2016;87:802–9.

    Google Scholar 

  21. Belaya K, Rodriguez Cruz PM, Liu WW, Maxwell S, McGowan S, Farrugia ME, Petty R, Walls TJ, Sedghi M, Basiri K, Yue WW, Sarkozy A, Bertoli M, Pitt M, Kennett R, Schaefer A, Bushby K, Parton M, Lochmuller H, Palace J, Muntoni F, Beeson D. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies. Brain. 2015;138:2493–504.

    Google Scholar 

  22. Klein A, Robb S, Rushing E, Liu WW, Belaya K, Beeson D. Congenital Myasthenic syndrome caused by mutations in DPAGT. Neuromuscul Disord. 2015;25:253–6.

    Article  PubMed  Google Scholar 

  23. Selcen D, Shen XM, Brengman J, Li Y, Stans AA, Wieben E, Engel AG. DPAGT1 myasthenia and myopathy: genetic, phenotypic, and expression studies. Neurology. 2014;82:1822–30.

    Google Scholar 

  24. Ertas M, Baslo MB, Yildiz N, Yazici J, Oge AE. Concentric needle electrode for neuromuscular jitter analysis. Muscle Nerve. 2000;23:715–9.

    Article  CAS  PubMed  Google Scholar 

  25. Sanders DB. Measuring jitter with concentric needle electrodes. Muscle Nerve. 2013;47:317–8.

    Article  PubMed  Google Scholar 

  26. Stalberg E. Jitter analysis with concentric needle electrodes. Ann N Y Acad Sci. 2012;1274:77–85.

    Article  PubMed  Google Scholar 

  27. Stalberg EV, Trontelj JV, Sanders DB. Single fibre EMG. Fiskebackskil, Lysekil: Edshagen Publishing House; 2010.

    Google Scholar 

  28. Gilchrist JM. Single fiber EMG reference values: a collaborative effort. Ad hoc committee of the AAEM special interest group on single fiber EMG. Muscle Nerve. 1992;15:151–61.

    Article  Google Scholar 

  29. Kouyoumdjian JA, Stalberg EV. Reference jitter values for concentric needle electrodes in voluntarily activated extensor digitorum communis and orbicularis oculi muscles. Muscle Nerve. 2008;37:694–9.

    Article  PubMed  Google Scholar 

  30. Kouyoumdjian JA, Stalberg EV. Concentric needle jitter on stimulated orbicularis oculi in 50 healthy subjects. Clin Neurophysiol. 2011;122:617–22.

    Article  PubMed  Google Scholar 

  31. Sarrigiannis PG, Kennett RP, Read S, Farrugia ME. Single-fiber EMG with a concentric needle electrode: validation in myasthenia gravis. Muscle Nerve. 2006;33:61–5.

    Article  PubMed  Google Scholar 

  32. Stalberg E, Trontelj JV. Single fiber electromyography studies in healthy and disease muscle. New York: Raven Press Ltd; 1994.

    Google Scholar 

  33. Trontelj JV, Fernandez JM. Single fiber EMG in juvenile idiopathic scoliosis. Muscle Nerve. 1988;11:297–300.

    Article  CAS  PubMed  Google Scholar 

  34. Valls-Canals J, Povedano M, Montero J, Pradas J. Stimulated single-fiber EMG of the frontalis and orbicularis oculi muscles in ocular myasthenia gravis. Muscle Nerve. 2003;28:501–3.

    Article  CAS  PubMed  Google Scholar 

  35. Jabre JF, Pitt MC, Deeb J, Chui KK. E-norms: a method to extrapolate reference values from a laboratory population. J Clin Neurophysiol. 2015;32:265–70.

    Article  PubMed  Google Scholar 

  36. Pitt MC, Jabre JF. Determining jitter values in the very young by use of the e-norms methodology. Muscle Nerve. 2017;55(1):51–4.

    Article  CAS  PubMed  Google Scholar 

  37. Verma S, Lin J. Stimulated jitter analysis for the evaluation of neuromuscular junction disorders in children. Muscle Nerve. 2016;53:471–2.

    Article  PubMed  Google Scholar 

  38. Verma S, Lin J, Barkhaus PE. Stimulated jitter analysis in the early diagnosis of infant botulism. Muscle Nerve. 2015;52:309–10.

    Article  PubMed  Google Scholar 

  39. Pitt MC, McHugh JC, Deeb J, Smith RA. Assessing neuromuscular junction stability from stimulated EMG in children. Clin Neurophysiol. 2017;128:290–6.

    Article  PubMed  Google Scholar 

  40. Lyu RK, Cheng SY, Tang LM. Electrodiagnostic studies in myasthenia gravis. Changgeng Yi Xue Za Zhi. 1993;16:164–9.

    CAS  PubMed  Google Scholar 

  41. SJ O, Kim DE, Kuruoglu R, Bradley RJ, Dwyer D. Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle Nerve. 1992;15:720–4.

    Article  Google Scholar 

  42. Sanders DB, Howard JF Jr. AAEE minimonograph #25: single-fiber electromyography in myasthenia gravis. Muscle Nerve. 1986;9:809–19.

    Article  CAS  PubMed  Google Scholar 

  43. Illingworth MA, Main M, Pitt M, Feng L, Sewry CA, Gunny R, Vorstman E, Beeson D, Manzur A, Muntoni F, Robb SA. RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine. Neuromuscul Disord. 2014;24:707–12.

    Google Scholar 

  44. Munot P, Lashley D, Jungbluth H, Feng L, Pitt M, Robb SA, Palace J, Jayawant S, Kennet R, Beeson D, Cullup T, Abbs S, Laing N, Sewry C, Muntoni F. Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord. 2010;20:796–800.

    Google Scholar 

  45. Robb SA, Sewry CA, Dowling JJ, Feng L, Cullup T, Lillis S, Abbs S, Lees MM, Laporte J, Manzur AY, Knight RK, Mills KR, Pike MG, Kress W, Beeson D, Jungbluth H, Pitt MC, Muntoni F. Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscul Disord. 2011;21:379–86.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Neurophysiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK

    Matthew Pitt M.D., F.R.C.P.

Authors
  1. Matthew Pitt M.D., F.R.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew Pitt M.D., F.R.C.P. .

Editor information

Editors and Affiliations

  1. Division of Neurology, Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada

    Hugh J. McMillan

  2. Division of Pediatric Neurology, Shands Children’s Hospital, University of Florida College of Medicine, Gainesville, Florida, USA

    Peter B. Kang

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Pitt, M. (2017). The Use of Stimulated EMG in the Diagnosis of Neuromuscular Junction Abnormality. In: McMillan, H., Kang, P. (eds) Pediatric Electromyography. Springer, Cham. https://doi.org/10.1007/978-3-319-61361-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61361-1_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61360-4

  • Online ISBN: 978-3-319-61361-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation